A new phase 2 trial reveals that a single dose of psilocybin, combined with psychological support, significantly reduces depression in over half of cancer patients, lasting up to two years.
A new clinical trial shows that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients. With promising long-term results, this therapy offers hope for many.
At just 26, I was dismissed by doctors as 'too young' for serious illness. This is my journey through misdiagnosis to understanding the reality of being part of 'Generation Cancer'. Read about the fight for recognition and the challenges young patients face.
A landmark study shows that a structured exercise program significantly improves survival rates and reduces cancer recurrence in colon cancer patients, urging healthcare systems to adopt exercise coaching as a standard care.
A groundbreaking study reveals that exercise can reduce cancer patients' risk of death by 37% and recurrence by 28%, proving it's even more effective than many drugs. This landmark trial could reshape health guidelines globally.
Emergency departments worldwide are seeing a troubling rise in undiagnosed cancers among young adults. These patients, seemingly healthy and without family histories, are often diagnosed too late. What does this mean for you?
A groundbreaking study reveals that immunotherapy drug dostarlimab has led to remarkable tumor disappearance in cancer patients, offering a new hope for those battling solid tumors.
A new study uncovers the concerning trend of many patients with incurable cancer not receiving adequate palliative care, opting for aggressive treatments instead. Learn more about the impact on end-of-life comfort and care planning.
